Volume 13, Number 8—August 2007
Research
Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission
Anthony D. Harris*†
, Jessina C. McGregor*, Judith A. Johnson*†, Sandra M. Strauss*, Anita C. Moore*, Harold C. Standiford‡, Joan N. Hebden‡, and J. Glenn Morris*
, Jessina C. McGregor*, Judith A. Johnson*†, Sandra M. Strauss*, Anita C. Moore*, Harold C. Standiford‡, Joan N. Hebden‡, and J. Glenn Morris*
Table 2
Independent predictors of ESBL-producing bacteria colonization in multivariable logistic regression model*
| Predictor | OR | 95% CI |
|---|---|---|
| Age >60 | 1.79 | 1.24, 2.60 |
| CDS-ID | 1.15 | 1.04, 1.27 |
| Vancomycin† | 2.11 | 1.34, 3.31 |
| Piperacillin-tazobactam† | 2.05 | 1.36, 3.10 |
*ESBL, extended-spectrum β-lactamase; OR, odds ratio; CI, confidence interval; CDS-ID, infectious disease–specific Chronic Disease Score.
†Antimicrobial drug exposures were assessed during the period between hospital admission and intensive care unit admission.
Page created: June 30, 2010
Page updated: June 30, 2010
Page reviewed: June 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.